Assembly Biosciences, Inc. Gains 72.18%
Tue, Oct 17, 2023 at 07:17 PM
Assembly Biosciences, Inc. (ASMB:NASDAQ) rocketted at $1.25, a gain of 72.2%. On Tue, Oct 17, 2023, ASMB:NASDAQ touched a New 2-Week High of $1.25. The stock got featured on our News Catalysts scanner on Tue, Oct 17, 2023 at 10:28 AM in the 'PATNERSHIP' category. From Tue, Oct 03, 2023, the stock recorded 50.00% Up Days and 27.27% Green Days
The stock spiked on Tue, Oct 17, 2023 at $1.67 with a volume of 75M+.
About Assembly Biosciences, Inc. (ASMB:NASDAQ)
Assembly Biosciences Inc is a clinical stage biotechnology company advancing two innovative platform programs, a new class of oral therapeutics for the treatment of hepatitis B virus infection and novel class of oral synthetic live biotherapeutics.
Top 10 Gainers:
- SciSparc Ltd. (SPRC:NASDAQ), 122.97%
- Nkarta Inc. (NKTX:NASDAQ), 112.16%
- Viveve Medical, Inc. (VIVE:NASDAQ), 78.95%
- Assembly Biosciences, Inc. (ASMB:NASDAQ), 72.18%
- Olink Holding AB (publ) (OLK:NASDAQ), 66.02%
- Aravive, Inc. (ARAV:NASDAQ), 61.9%
- Anebulo Pharmaceuticals Inc. (ANEB:NASDAQ), 42.69%
- RedHill Biopharma Ltd. (RDHL:NASDAQ), 34.1%
- Gamer Pakistan Inc. (GPAK:NASDAQ), 32%
- Ramaco Resources, Inc. (METC:NASDAQ), 28.82%